David M. Nanus

1.1k total citations
27 papers, 902 citations indexed

About

David M. Nanus is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, David M. Nanus has authored 27 papers receiving a total of 902 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 10 papers in Pulmonary and Respiratory Medicine and 9 papers in Oncology. Recurrent topics in David M. Nanus's work include Peptidase Inhibition and Analysis (4 papers), Prostate Cancer Treatment and Research (4 papers) and Renal and related cancers (3 papers). David M. Nanus is often cited by papers focused on Peptidase Inhibition and Analysis (4 papers), Prostate Cancer Treatment and Research (4 papers) and Renal and related cancers (3 papers). David M. Nanus collaborates with scholars based in United States, Canada and Israel. David M. Nanus's co-authors include Anthony P. Albino, Neil H. Bander, Jan Bressler, Carlos Cordon‐Cardo, N. Scott McNutt, Michael Andreeff, Ruoqian Shen, Yiping Geng, Klaus A. Hamacher and Shota Konishi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and The Journal of Experimental Medicine.

In The Last Decade

David M. Nanus

25 papers receiving 887 citations

Peers

Countries citing papers authored by David M. Nanus

Since Specialization

Citations

This map shows the geographic impact of David M. Nanus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David M. Nanus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David M. Nanus more than expected).

Fields of papers citing papers by David M. Nanus

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David M. Nanus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David M. Nanus. The network helps show where David M. Nanus may publish in the future.

Co-authorship network of co-authors of David M. Nanus

This figure shows the co-authorship network connecting the top 25 collaborators of David M. Nanus. A scholar is included among the top collaborators of David M. Nanus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David M. Nanus. David M. Nanus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Unusual Presentation of Advanced Urothelial Cancer in a Young Patient 2025 ·Anticancer Research ·(unknown), Nara Shin, (unknown), (unknown), (unknown), Juan Miguel Mosquera, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Olivier Elemento, David M. Nanus, Cora N. Sternberg	0
2	1974: Acute Toxicity in a Randomized Trial of MRI-guided Salvage RT for Prostate Cancer in 4 vs. 2 Weeks 2024 ·Radiotherapy and Oncology ·Himanshu Nagar, Xi Kathy Zhou, (unknown), Christopher E. Barbieri, Silvia C. Formenti, Jim C. Hu, Ana Ramı́rez de Molina, David M. Nanus, Jones T. Nauseef, Douglas S. Scherr, Cora N. Sternberg, Scott T. Tagawa, Ariel E. Marciscano	0
3	NDUFA4L2 reduces mitochondrial respiration resulting in defective lysosomal trafficking in clear cell renal cell carcinoma 2023 ·Cancer Biology & Therapy ·(unknown), Kristian B. Laursen, (unknown), Ryan M. Williams, Johannes C. van der Mijn, Michael J. Crowley, Nigel P. Mongan, David M. Nanus, Daniel A. Heller, Lorraine J. Gudas	12
4	Nearly All Cancer Survivors Return to Primary Care 2022 ·The Journal of the American Board of Family Medicine ·Laura C. Pinheiro, Mangala Rajan, Monika M. Safford, David M. Nanus, Lisa M. Kern	10
5	Mitochondrial Ndufa4l2 Enhances Deposition of Lipids and Expression of Ca9 in the TRACK Model of Early Clear Cell Renal Cell Carcinoma 2021 ·Frontiers in Oncology ·Kristian B. Laursen, Qiuying Chen, Francesca Khani, Nabeel Attarwala, Steve Gross, Lukas E. Dow, David M. Nanus, Lorraine J. Gudas	10
6	<em>In vitro</em> Method to Observe E-selectin-mediated Interactions Between Prostate Circulating Tumor Cells Derived From Patients and Human Endothelial Cells 2014 ·Journal of Visualized Experiments ·Gunjan Gakhar, Neil H. Bander, David M. Nanus	2
7	Circulating Tumor Cells from Prostate Cancer Patients Interact with E-Selectin under Physiologic Blood Flow 2013 ·PLoS ONE ·Gunjan Gakhar, (unknown), (unknown), (unknown), Scott T. Tagawa, Naveed Akhtar, Marco Seandel, Yue Geng, Liu He, Neil H. Bander, Paraskevi Giannakakou, Paul J. Christos, Michael R. King, David M. Nanus	36
8	Adenoviral neutral endopeptidase gene delivery in combination with paclitaxel for the treatment of prostate cancer 2012 ·International Journal of Oncology ·David M. Nanus	7
9	Rational redesign of neutral endopeptidase binding to merlin and moesin proteins 2009 ·Protein Science ·Masha Y. Niv, Katsuyuki Iida, Rong Zheng, Akio Horiguchi, Ruoqian Shen, David M. Nanus	3
10	Synaptic Activity Reduces Intraneuronal Aβ, Promotes APP Transport to Synapses, and Protects against Aβ-Related Synaptic Alterations 2009 ·Journal of Neuroscience ·Davide Tampellini, (unknown), Eduardo F. Gallo, Zhenyong Huang, Magali Dumont, Estibaliz Capetillo‐Zarate, Tao Ma, (unknown), Bao Lu, David M. Nanus, Michael T. Lin, Gunnar K. Gouras	105
11	Modulation of 11β-Hydroxysteroid Dehydrogenase Expression by Bombesin: A Possible Mechanism for Glucocorticoid Resistance in Androgen Independent Prostate Cancer 2008 ·Hormone and Metabolic Research ·Ji Hyun Lee, (unknown), Daniel B. Hardy, Kin Fon Leong, David M. Nanus, Matthew P. Hardy, R Shen	2
12	Interaction of prostate specific membrane antigen with clathrin and the adaptor protein complex-2 2007 ·International Journal of Oncology ·Neil H. Bander, Ayyappan K. Rajasekaran, David M. Nanus, James H. Keen, (unknown), Peter S. McPherson, Brigitte Ritter, Sonali P. Barwe, Oscar B. Goodman	28
13	Retinoid receptor mRNA expression profiles in human bladder cancer specimens 2005 ·International Journal of Oncology ·Stephen A. Boorjian, Douglas S. Scherr, Nigel P. Mongan, Yong Zhuang, David M. Nanus, Lorraine J. Gudas	11
14	Renal Cell Carcinoma and Interferon at the Millennium 2001 ·Cancer Investigation ·Raymond D. Pastore, Lawrence M. Pfeffer, David M. Nanus	5
15	Neutral endopeptidase inhibits prostate cancer cell migration by blocking focal adhesion kinase signaling 2000 ·Journal of Clinical Investigation ·Makoto Sumitomo, Ruoqian Shen, (unknown), Jie Dai, Yiping Geng, Daniel Navarro, Guy Boileau, Christos N. Papandreou, (unknown), Beatrice S. Knudsen, David M. Nanus	124
16	The development of biologic end points in patients treated with differentiation agents: an experience of retinoids in prostate cancer. 2000 ·PubMed ·William K. Kelly, Iman Osman, Victor E. Reuter, Tracy Curley, Warren D.W. Heston, David M. Nanus, Howard I. Scher	45
17	Molecular cloning of the human kidney differentiation antigen gp160: human aminopeptidase A. 1993 ·Proceedings of the National Academy of Sciences ·David M. Nanus, Dov Engelstein, G Gastl, Louis Gluck, Marcos Vidal, Martin Morrison, Connie L. Finstad, Neil H. Bander, Anthony P. Albino	91
18	Ras oncogene point mutation: An infrequent event in bronchioloalveolar cancer 1992 ·Journal of Thoracic and Cardiovascular Surgery ·Valerie W. Rusch, Victor E. Reuter, Mark G. Kris, Jonathan M. Kurie, Wilson H. Miller, David M. Nanus, Anthony P. Albino, Ethan Dmitrovsky	10
19	Systemic chemotherapy in the management of bladder cancer 1989 ·Cancer treatment and research ·David M. Nanus, George J. Bosl	1
20	Transformation of human kidney proximal tubule cells by ras-containing retroviruses. Implications for tumor progression. 1989 ·The Journal of Experimental Medicine ·David M. Nanus, Salah Ebrahim, Neil H. Bander, Francisco X. Real, Lawrence M. Pfeffer, Joan Rankin Shapiro, Anthony P. Albino	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact